A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Eli Lilly and Company
Eli Lilly and Company
Taproot Health
Scripps Health
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
Roswell Park Cancer Institute
University of Chicago
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Alliance for Clinical Trials in Oncology
Morphotek
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
Cellerant Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
SWOG Cancer Research Network
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Northwestern University
Case Comprehensive Cancer Center